Randomized Investigation of Heart Failure Therapy in Patients with Advanced Cancer at Risk of Cardiac Wasting: Rationale and Design of the EMPATICC Trial
EMPATICC evaluates whether HF therapy can improve function and well-being in advanced cancer, potentially reshaping care in this population.
Authors
- Markus S. Anker (ORCID: https://orcid.org/0000-0002-4406-8555)
- Lorenz Lehmann (ORCID: https://orcid.org/0000-0001-5077-8580)
- Marius Placzek (ORCID: https://orcid.org/0000-0002-8663-5378)
- Sven Bercker
- Javed Butler (ORCID: https://orcid.org/0000-0001-7683-4720)
- Johann Ahn (ORCID: https://orcid.org/0000-0002-5631-4143)
- Ulrich Bernd Keller (ORCID: https://orcid.org/0000-0002-8485-1958)
- Muhammad Shahzeb Khan (ORCID: https://orcid.org/0000-0002-6578-4753)
- Martin Hellmich (ORCID: https://orcid.org/0000-0001-5174-928X)
- Lars Bullinger (ORCID: https://orcid.org/0000-0002-5890-5510)
- Raluca Mincu (ORCID: https://orcid.org/0000-0002-9032-2630)
- Amir Abbas Mahabadi (ORCID: https://orcid.org/0000-0003-2336-7991)
- Dominik Paul Modest (ORCID: https://orcid.org/0000-0002-6853-0599)
- Tim Friede (ORCID: https://orcid.org/0000-0001-5347-7441)
- Tienush Rassaf (ORCID: https://orcid.org/0000-0001-8001-0265)
- Tim Heise (ORCID: https://orcid.org/0000-0002-8346-2037)
- Monika Diek
- Mitra Tewes (ORCID: https://orcid.org/0000-0001-8868-8329)
- Ulf Landmesser (ORCID: https://orcid.org/0000-0002-0214-3203)
- Matthias Totzeck (ORCID: https://orcid.org/0000-0001-5574-948X)
- Michael Böhm (ORCID: https://orcid.org/0000-0002-2976-2514)
- Stefan D. Anker
- Bela Merkely
Institutions
- Semmelweis University (HU)
- German Cancer Research Center (DE)
- Baylor College of Medicine (US)
- Max Delbrück Center (DE)
- Heidelberg University (DE)
- Temple College (US)
- University Hospital Heidelberg (DE)
- Jackson Memorial Hospital (US)
- University of Mississippi Medical Center (US)
- Humboldt-Universität zu Berlin (DE)
- Universitätsklinikum des Saarlandes (DE)
- Deutsches Herzzentrum der Charité (DE)
- Baylor Medical Center at Garland (US)
- National Center for Tumor Diseases (DE)
- Heart Hospital Baylor Plano (US)
- Universitätsmedizin Göttingen (DE)
- Essen University Hospital (DE)
- German Marine Research Consortium (DE)
- University Hospital Leipzig (DE)
- German Centre for Cardiovascular Research (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Klinik und Poliklinik für Neurologie (DE)
- Deutsches Herzzentrum München (DE)
- Berlin Heart (Germany) (DE)
- West German Heart and Vascular Center Essen (DE)
- Profil Institute for Metabolic Research (DE)
- Franklin University (US)
- University of Duisburg-Essen (DE)
- Charité - Universitätsmedizin Berlin (DE)
- University of Glasgow (GB)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1002/ejhf.3799
- Citations
- 4
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 5.55
Funders
- European Society of Cardiology